U.S., EU investigate link between Raptiva, brain disease

02/19/2009 | Bloomberg · Los Angeles Times (tiered subscription model)

The FDA and the European Medicines Agency are investigating a possible link between Genentech's psoriasis drug Raptiva and progressive multifocal leukoencephalopathy, a deadly brain infection. The agencies received three reports of deaths and one possible case of the disease. Genentech and its European partner Merck KGaA said they are working with the regulators to address the issue.

View Full Article in:

Bloomberg · Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ